By Barry Zakar on
1/18/2011 2:57 PM
With impending changes to the FDA 510(k) process and payers raising the bar for reimbursement, we need to improve our understanding of clinical trials.
Read More »
|
By Barry Zakar on
8/2/2010 12:58 PM
At some point in our company’s development, it may be helpful to consider distributing one or more products from other companies. Medical device manufacturers with a direct sales force often choose to distribute other products along with their own.
Read More »
|
By Barry Zakar on
6/17/2010 1:48 PM
In the long run, practice-changing or disruptive technology benefits patients, healthcare professionals, payers and the company providing it. But how do we drive these innovative practice-changing technologies to a standard of care?
Read More »
|
By Barry Zakar on
5/27/2010 1:17 PM
The scientific sessions are over for another year. We have counted the leads and other successes and are now ready to follow-up. What can we do to capture and harness the momentum from our successful exhibit?
Read More »
|
By Barry Zakar on
4/19/2010 9:16 AM
Now that our exhibit is designed and in-place, we need to think about activities that will maximize the draw of potential customers, producing leads and providing the best ROI on our exhibit investment.
Read More »
|
By Barry Zakar on
4/5/2010 10:10 AM
Once we are comfortable with our theme and/or positioning, we can move on to tactical implementation specific to our exhibit. Once we have contracted for our exhibit space and services, we should consider pre-show marketing activities.
Read More »
|
By Barry Zakar on
3/26/2010 9:30 AM
One of the most frequently requested services from my clients is assistance with exhibiting at key scientific sessions. These sessions may be the venue for a product launch, or simply a large, important meeting for the client company and they want to maximize their marketing and sales impact.
Read More »
|